Article Information
History
- June 18, 2018.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Jeffrey Westa,*,
- Mark Robertson-Tessia,
- Kimberly Luddyb,c,
- Derek S. Parka,
- Drew F.K. Williamsond,
- Cathal Harmonc,
- Hung T. Khonge,
- Joel Browna,f and
- Alexander R.A. Andersona,*
- aDepartment of Integrated Mathematical Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida
- bDepartment of Cancer Imaging and Metabolism, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida
- cSchool of Biochemistry and Immunology, Trinity College Dublin, Dublin, Ireland
- dTranslational Hematology and Oncology Research, Cleveland Clinic Foundation
- eChemical Biology and Molecular Medicine, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida
- fDepartment of Biological Sciences, University of Illinois at Chicago, Chicago, IL, 60607, USA
- ↵*corresponding authors: jeffrey.west{at}moffitt.org and alexander.anderson{at}moffitt.org
Posted June 18, 2018.
The immune checkpoint kick start: Optimization of neoadjuvant combination therapy using game theory
